© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 13, 2021
Key opinion leaders emphasize important considerations when discussing the safety of anti-VEGF agents with patients and highlight unmet needs in nonproliferative diabetic retinopathy treatments.
December 08, 2021
Drs Ehsan Rahimy and Joseph M. Coney analyze the implications of clinical trial data on the management of nonproliferative diabetic retinopathy.
A panel of experts reviews data on nonproliferative diabetic retinopathy treatments from the PANORAMA, Protocol W, RISE, and RIDE studies.
November 30, 2021
Dr Joseph M. Coney provides insight into the goals of therapy for patients with nonproliferative diabetic retinopathy.
AMD Appeared More Common In Older, Female Patients at Rural Tertiary Care Hospital
Intravitreal Dexamethasone Implant Appeared Positive for Eyes with RVO-ME
Highly Aspherical Lenslet Spectacles Help Stop Progression of Myopia